Precigen
PGEN
#5417
Rank
A$2.23 B
Marketcap
A$6.24
Share price
-2.58%
Change (1 day)
-16.31%
Change (1 year)

Earnings for Precigen (PGEN)

Earnings in 2026 (TTM): A$34.26 Million

According to Precigen's latest financial reports the company's current earnings are A$0.15 Billion. In 2025 the company made an earning of -A$0.38 Billion a decrease over its 2024 earnings that were of -A$0.2 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Precigen from 2012 to 2026

Annual earnings

Year Earnings Change
2026 (TTM) A$34.26 M-109.12%
2025 -A$0.38 Billion95.77%
2024 -A$0.2 Billion32.86%
2023 -A$0.15 Billion20.5%
2022 -A$0.12 Billion-23.33%
2021 -A$0.16 Billion60.11%
2020 -A$97.65 Million-65.1%
2019 -A$0.28 Billion-65.19%
2018 -A$0.81 Billion313.44%
2017 -A$0.2 Billion-33.2%
2016 -A$0.3 Billion123.22%
2015 -A$0.14 Billion1.47%
2014 -A$0.13 Billion109.54%
2013 -A$61.33 Million-50.04%
2012 -A$0.13 Billion

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Organovo
ONVO
-A$3.73 Million-110.10%๐Ÿ‡บ๐Ÿ‡ธ USA
Orchard Therapeutics
ORTX
-A$0.11 Billion-396.94%๐Ÿ‡ฌ๐Ÿ‡ง UK
Novavax
NVAX
-A$0.34 Billion-1,008.02%๐Ÿ‡บ๐Ÿ‡ธ USA
Novocure
NVCR
-A$0.14 Billion-465.61% Jersey